logo

Sarcoma

Sarcoma / 2019 / Article / Tab 1

Research Article

Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage

Table 1

Demographic and clinical characteristics of uterine LMS patients stratified by receipt of chemotherapy.
CharacteristicsChemotherapy No chemotherapy
Number%Number%
Age at diagnosis, y    <0.0001
 18–39667.11076.0 
 40–4927028.846726.0 
 50–6447550.779444.2 
 65+12513.442823.8 
Race (missing from analysis: )    0.7531
 White70179.7132778.4 
 African American17920.336521.6 
Hispanic (missing from analysis: )    0.0292
 Yes798.81116.5 
 No81491.2159693.5 
Comorbidities (Charlson/Deyo score)    0.1509
 078784.1146081.3 
 112613.527515.3 
 2232.5613.4 
Insurance status (missing from analysis: )    <0.0001
 Medicare12213.244224.9 
 Private65771.0111262.8 
 Medicaid/Other government899.61206.8 
 None576.2985.5 
Median household income ($) (missing from analysis: )    0.4726
 <38,00016417.732918.6 
 38,000–47,99919821.436620.7 
 48,000–62,99925227.244124.9 
 >63,00031133.663435.8 
Education (% no high school diploma) (missing from analysis: )    0.0355
 ≥2116617.932118.1 
 13–20.918520.043724.7 
 7–12.933536.257632.5 
 <723925.843624.6 
Location of patient (missing from analysis: )    0.0902
 Large metropolitan57462.7101358.7 
 Small metropolitan23625.848428.0 
 Suburban758.21458.4 
 Rural303.3854.9 
Hospital volume (cases per year)    0.0181
 0.09384.1995.5 
 0.18–0.2710311.025614.3 
 0.36–0.5518119.335319.7 
 0.64–7.2761465.6108860.6 
Regional lymph nodes positive (missing from analysis: )    <0.0001
 Yes308.0132.0 
 No34792.064298.0 
Stage    <0.0001
 167672.2154185.8 
 2646.81166.5 
 319620.91397.7 
Year of diagnosis    <0.0001
 2004–200934536.9100556.0 
 2010–201459163.179144.0 
Radiation (missing from analysis: )    0.0406
 Yes22524.337320.9 
 No70075.7141379.1 
Oophorectomy (missing from analysis: )    0.6492
 Yes71684.0143784.7 
 No13616.025915.3